What is TAC Cream (Tacrolimus)?
TAC cream is the common name for topical tacrolimus, a prescription ointment sold under brand names like Protopic® [1.4.2]. It belongs to a class of drugs called topical calcineurin inhibitors (TCIs) [1.2.1]. This medication is not a steroid. It's primarily used as a second-line treatment for moderate to severe atopic dermatitis (eczema) when other medications, such as topical corticosteroids, are ineffective or not advisable [1.4.3, 1.2.3]. Tacrolimus is available in two strengths: 0.03% and 0.1% [1.9.2]. The 0.03% strength is approved for children aged 2 to 15, while adults can use either strength [1.9.3].
How Does It Work?
The primary function of TAC cream is to modulate the body's immune response in the skin. Eczema is an allergic-type condition characterized by an overactive immune system response that leads to inflammation, redness, and itching [1.2.1]. Tacrolimus works by inhibiting calcineurin, a protein that activates T-cells, which are a type of immune cell [1.3.3, 1.3.4]. By binding to a specific protein within these T-cells, it blocks the production and release of inflammatory cytokines—substances that cause the symptoms of eczema [1.3.1, 1.3.2]. This action weakens the skin's immune defense system, thereby decreasing the allergic reaction and relieving the eczema symptoms [1.2.1].
Primary Uses and Applications
Atopic Dermatitis (Eczema) The most common use for tacrolimus ointment is treating moderate to severe atopic dermatitis [1.4.3]. It is particularly beneficial for sensitive skin areas where topical steroids could cause skin thinning (atrophy), such as the face, eyelids, and skin folds [1.7.1, 1.3.3]. It's typically applied as a thin layer to the affected areas twice daily [1.6.2]. Treatment should continue until the signs and symptoms of eczema clear up and can be restarted if symptoms reappear, but it is not intended for continuous long-term use [1.2.1].
Off-Label Use: Vitiligo Tacrolimus is also used off-label to treat vitiligo, a condition that causes the loss of skin color in patches [1.8.4]. Its immunomodulatory effects can help in the repigmentation process, especially on the head and neck [1.8.3]. Studies have shown that combining tacrolimus with phototherapy (like narrow-band UVB) can be an effective treatment for non-segmental vitiligo [1.8.4]. In March 2024, France authorized its use for vitiligo through a compassionate prescription framework [1.8.2].
How to Properly Apply TAC Cream
Correct application is crucial for the medication's effectiveness and safety:
- Wash Hands: Always wash your hands with soap and water before and after application, unless your hands are the treatment area [1.6.2].
- Ensure Skin is Dry: Apply the ointment to clean, completely dry skin [1.6.3].
- Apply a Thin Layer: Use the smallest amount necessary to cover the affected skin with a thin layer. Rub it in gently and completely [1.6.2].
- Avoid Washing Off: Do not bathe, shower, or swim immediately after applying the ointment, as this can wash it off [1.6.2].
- No Occlusive Dressings: Do not cover the treated skin with bandages or wraps unless directed by a doctor [1.6.2]. Normal clothing is fine.
- Moisturizers: If you use moisturizers, apply them after applying tacrolimus ointment [1.10.4].
Comparison with Topical Corticosteroids
Feature | Tacrolimus (TAC Cream) | Topical Corticosteroids |
---|---|---|
Mechanism | Calcineurin inhibitor; suppresses T-cell activation [1.3.3]. | Anti-inflammatory; constricts blood vessels. |
Primary Use | Second-line for moderate-to-severe eczema [1.2.3]. | First-line for many inflammatory skin conditions [1.7.1]. |
Side Effects | Main side effect is skin burning/stinging, which usually subsides [1.2.2]. Carries a black box warning for a theoretical cancer risk [1.5.1]. | Long-term use can cause skin atrophy (thinning), striae, and telangiectasia [1.7.1]. |
Use on Face/Folds | Considered safer for long-term use on sensitive areas as it does not cause skin atrophy [1.7.1, 1.3.3]. | Use of potent steroids is often limited in these areas due to the risk of atrophy [1.7.1]. |
Efficacy | 0.1% strength has similar effectiveness to moderate-to-high potency corticosteroids [1.7.1]. | Potency varies widely, from mild to super-potent [1.7.4]. |
Important Safety Information and Side Effects
Black Box Warning The U.S. Food and Drug Administration (FDA) has issued a boxed warning for tacrolimus. This is the most serious warning from the FDA [1.5.1]. It notes that a small number of people using TCIs have developed cancers like lymphoma and skin cancer, although a direct causal link has not been established [1.5.1, 1.5.2]. Due to this theoretical risk, tacrolimus is recommended for short-term, intermittent use and not for continuous long-term application [1.10.4].
Common Side Effects The most frequent side effects occur at the application site and are usually temporary [1.10.2]:
- Skin burning, stinging, or itching, especially during the first few days of treatment [1.2.1].
- Skin redness [1.5.3].
- Increased skin sensitivity to hot or cold temperatures [1.2.1].
Other potential side effects include flu-like symptoms, headache, acne, and swollen hair follicles [1.2.1, 1.5.5].
Precautions
- Sun Exposure: Patients should minimize or avoid natural and artificial sunlight (tanning beds, UV light therapy) on treated areas. Use sunscreen and protective clothing when outdoors [1.10.1, 1.6.2].
- Alcohol: Drinking alcohol while using tacrolimus may cause the skin or face to become flushed and feel hot [1.10.5].
- Weakened Immune System: This medication should not be used by individuals with a weakened immune system [1.10.5].
- Infections: Do not apply to areas with active viral or bacterial skin infections [1.5.3].
Conclusion
So, what does TAC cream do? It serves as a valuable non-steroidal treatment for inflammatory skin conditions, most notably atopic dermatitis, by suppressing the local immune response. While it offers a significant advantage over steroids by not causing skin atrophy, making it suitable for sensitive areas, its use requires careful consideration of the potential risks outlined in its black box warning. Patients should always use tacrolimus exactly as prescribed by their healthcare provider, be vigilant about sun protection, and report any unusual symptoms or lack of improvement after 6 weeks of treatment [1.2.1].
For more detailed information, consult the FDA Medication Guide for Protopic®.